1 min to read News Posted on March 2, 2023 StockWatch: Pfizer Scales Patent Cliff by Pursuing Seagen Deal – Genetic Engineering & Biotechnology News StockWatch: Pfizer Scales Patent Cliff by Pursuing Seagen Deal Source: StockWatch: Pfizer Scales Patent Cliff by Pursuing Seagen Deal – Genetic Engineering & Biotechnology News share tweet share What Will Crypto SPACs Look Like in 2023?Report: SPACs and De-SPACing: Considerations for Going Public Through a Combination with a SPACSPACs: Are You Really Ready To Commit?5 things you really should not buy in 2023 – Morningstar Tags: SPACs